GE HealthCare wins FDA nod for photon-counting CT system
March 23, 2026
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Photonova Spectra solution.
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Photonova Spectra solution.
By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students.
Built for high reliability, world’s only lumenless defibrillation lead approved for placement in the left bundle branch area
This breakthrough could lead to next-generation medical tools that track disease, guide treatment and monitor the body in real time
The method relies on the fact that deuterium, once in the body, participates in biochemical reactions alongside ordinary hydrogen and becomes incorporated into the carbon-hydrogen bonds of organic compounds.
Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy.
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients.
Powerful brain imaging has helped uncover why people with post-traumatic stress disorder (PTSD) who engage in negative self-talk may be struggling with the first line of treatment. The discovery, published in Nature Mental Health, sheds new light as to why underlying brain mechanisms mean some therapies potentially work for some people and not others, and could guide the development of more targeted treatments for PTSD.
Could wounded skin someday regrow perfectly without scars? A new study by Harvard stem cell biologists published in Cell reveals a way to fully regenerate skin by unblocking an embryonic healing mechanism that shuts off after birth. Demonstrated on mice, the study suggests a potential means to develop similar therapies in human patients.
Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian—offers the prospect of better care for many thousands of patients who may be overlooked due to the difficulty of diagnosing their condition.